Our research continues to advance the understanding of autonomic dysfunction as it relates neurodegenerative diseases such as MS, Parkinson’s, ALS, Lyme, and conditions such as Fibromyalgia, Chronic Fatigue Syndrome, POTS, and others. Our diagnosis and treatment program is unmatched, as is evidenced by our high patient response rates.
Michael Arata, M.D.
Dr. Arata is an accomplished physician internationally respected for his work in Interventional Medicine. He specializes in treating chronic venous obstruction and venous occlusive disease. His experience in this area spans for more than a decade, long before the discovery of CCSVI. He has performed several thousand of central venograms and angioplasties for blocked veins for a variety of different diseases and over 1500 CCSVI/TVAM procedures.
Our Success Rates
We’ve performed over 1500 procedures, maintaining a 99% technical success rate, and a clinical (patient response) success rate in excess of 90%. Our treatment program begins with a clinical assessment, followed by HRV and MRV testing. Patients showing autonomic symptoms who test positive for autonomic dysfunction are approved for the procedure. Symptom relief begins during and directly after the procedure, and is durable in excess of 2 years or more than 75% of patients.
In the video above, Colleen, a patient with MS and CCSVI talks about her experience before, during, and after her procedure. We invite you to meet and interact with the growing pool of patients treated at Synergy Health. Many of our patients are active on the Synergy Facebook and Synergy Twitter, and regularly contribute to the conversation online. For more information, read Testimonials from Synergy Health patients and get involved with CCSVI patient organization and support groups.